ATE410448T1 - Neues peptid und pharmazeutische zusammensetzung, die dieses peptid enthält - Google Patents
Neues peptid und pharmazeutische zusammensetzung, die dieses peptid enthältInfo
- Publication number
- ATE410448T1 ATE410448T1 AT05793330T AT05793330T ATE410448T1 AT E410448 T1 ATE410448 T1 AT E410448T1 AT 05793330 T AT05793330 T AT 05793330T AT 05793330 T AT05793330 T AT 05793330T AT E410448 T1 ATE410448 T1 AT E410448T1
- Authority
- AT
- Austria
- Prior art keywords
- peptide
- pharmaceutical composition
- composition containing
- cell
- new
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 230000004075 alteration Effects 0.000 abstract 2
- 210000002615 epidermis Anatomy 0.000 abstract 1
- 108010028309 kalinin Proteins 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 230000003014 reinforcing effect Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Birds (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0408383A FR2873698B1 (fr) | 2004-07-29 | 2004-07-29 | Nouveau peptide et composition pharmaceutique le contenant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE410448T1 true ATE410448T1 (de) | 2008-10-15 |
Family
ID=34950308
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05793330T ATE410448T1 (de) | 2004-07-29 | 2005-07-29 | Neues peptid und pharmazeutische zusammensetzung, die dieses peptid enthält |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7645740B2 (de) |
| EP (1) | EP1784423B1 (de) |
| AT (1) | ATE410448T1 (de) |
| CA (1) | CA2575387C (de) |
| DE (1) | DE602005010276D1 (de) |
| ES (1) | ES2317308T3 (de) |
| FR (1) | FR2873698B1 (de) |
| WO (1) | WO2006018551A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2943062B1 (fr) | 2009-03-13 | 2011-04-08 | Symatese | Nouveau peptide promoteur de l'adhesion et de la migration cellulaire |
| KR102065171B1 (ko) * | 2019-02-20 | 2020-01-13 | (주)케어젠 | 대기오염물질에 의한 피부 손상 방지 및 항노화용 펩타이드와 이의 용도 |
| KR102539445B1 (ko) | 2020-11-25 | 2023-06-05 | (주)케어젠 | 미세먼지에 의한 세포 손상 방지 활성을 갖는 펩타이드 및 이의 용도 |
| KR102474470B1 (ko) * | 2020-11-25 | 2022-12-07 | (주)케어젠 | 미세먼지에 의한 세포 손상 방지 활성을 갖는 펩타이드 및 이의 용도 |
| FR3127219B1 (fr) * | 2021-09-20 | 2025-04-11 | Laboratoires Danjou | Nouveaux peptides et compositions pharmaceutiques et cosmetiques les contenants |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6294356B1 (en) * | 1998-01-16 | 2001-09-25 | Northwestern University | Methods and materials for making and using laminin-5 |
| EP1177290A2 (de) * | 1999-04-30 | 2002-02-06 | Biostratum, Inc. | Rekombinantes laminin 5 |
| JP4377522B2 (ja) * | 2000-05-09 | 2009-12-02 | 株式会社ヤクルト本社 | 安定な酸性乳飲料、その製造方法およびこれに使用する酸性乳飲料用添加剤 |
-
2004
- 2004-07-29 FR FR0408383A patent/FR2873698B1/fr not_active Expired - Fee Related
-
2005
- 2005-07-29 DE DE602005010276T patent/DE602005010276D1/de not_active Expired - Lifetime
- 2005-07-29 EP EP05793330A patent/EP1784423B1/de not_active Expired - Lifetime
- 2005-07-29 US US11/572,774 patent/US7645740B2/en not_active Expired - Lifetime
- 2005-07-29 WO PCT/FR2005/001999 patent/WO2006018551A1/fr not_active Ceased
- 2005-07-29 ES ES05793330T patent/ES2317308T3/es not_active Expired - Lifetime
- 2005-07-29 AT AT05793330T patent/ATE410448T1/de not_active IP Right Cessation
- 2005-07-29 CA CA2575387A patent/CA2575387C/fr not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA2575387A1 (fr) | 2006-02-23 |
| DE602005010276D1 (de) | 2008-11-20 |
| WO2006018551A1 (fr) | 2006-02-23 |
| FR2873698B1 (fr) | 2006-10-20 |
| WO2006018551A8 (fr) | 2006-04-27 |
| US20080064641A1 (en) | 2008-03-13 |
| EP1784423A1 (de) | 2007-05-16 |
| EP1784423B1 (de) | 2008-10-08 |
| FR2873698A1 (fr) | 2006-02-03 |
| CA2575387C (fr) | 2014-09-02 |
| ES2317308T3 (es) | 2009-04-16 |
| US7645740B2 (en) | 2010-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2027152T3 (da) | Peptidfragmenter til induktion af syntese af ekstracellulære matrixproteiner | |
| BR0308429A (pt) | Aroilpiridinonas monocìclicas como agentes antiinflamatórios | |
| UY27127A1 (es) | Derivados de la urea como antagonistas de integrin alfa-4 | |
| NZ592911A (en) | Leukolectins and uses thereof | |
| UY28258A1 (es) | Tratamiento terapeutico | |
| EE05212B1 (et) | Polpeptiidi kasutamine farmatseutilise kompositsiooni valmistamiseks, mis on m?eldud kasvajaraku raviks, mis ekspresseerib APRIL-i | |
| ATE419859T1 (de) | Verwendung von probiotischen bakterien zur herstellung von topischen zusammensetzungen zum schutz der haut | |
| MXPA06003474A (es) | Agonistas de receptores de melanocortina. | |
| MX2007005723A (es) | Articulos para tratamiento que pueden amoldarse a una forma subyacente. | |
| ES2530670T3 (es) | Anticuerpo anti-FGF23 y composición farmacéutica que comprende el mismo | |
| DE60125563D1 (de) | Verfahren zur verwendung eines humanen il-17 verwandten polypeptids zur behandlung von krankheiten | |
| EP1962843A4 (de) | Verwendung von parp-1-hemmern | |
| ATE410448T1 (de) | Neues peptid und pharmazeutische zusammensetzung, die dieses peptid enthält | |
| DE602006012115D1 (de) | Behandlung von amyotrophischer lateralsklerose mit pyrimethamin und analoga | |
| ATE526056T1 (de) | Igf-2 peptid zur verwendung in einer tolerogenen behandlung für typ i diabetes | |
| DE602004019141D1 (de) | Isoleucyl-valyl-threonyl-asparaginyl-threonyl-threonin (ivtntt) enthaltende biologisch wirksame peptide | |
| CY1108048T1 (el) | Συνθεση σπογγοσινης | |
| ATE540968T1 (de) | Alpha-fetoproteinpeptide und deren verwendungen | |
| ATE281178T1 (de) | Protonenpumpenhemmer als kombinationstherapeutika mit antibakterielle wirkenden substanzen | |
| YU70903A (sh) | Novi peptid ligandi za integrine leukocita | |
| DK1748785T3 (da) | Peptider til modulering af bruskhomeostase | |
| DK1569961T3 (da) | Splice variant af det menneskelige hypofysevæksthormon | |
| HN2003000193A (es) | Uso de inhibidores de vasopeptidasa en el tratamiento de enfermedades metabolicas, nefropatia y enfermedades asociadas con age. | |
| SE0700513L (sv) | Kosmetiska kompositioner | |
| ATE369190T1 (de) | Eine, ein peptid und ein pigment enthaltende zusammensetzung und deren verwendung zur hautbräunung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |